As we showed that the combination of PD-1 and CTLA-4 expression is correlated to metastatic diseases, we hypothesize that the expression of these checkpoint molecules may be an early marker for micro metastatic diseases undetectable by cross-sectional imaging. This evidence concerns the gene CTLA4 and metastatic neoplasm.